Canadian HIV Clinical Forum 2018

Related Enduring Materials

Enduring Materials

Day 1 - Friday, 15 June 2018

Session 1: Optimizing Routine HIV Clinical Management - Resistance -

State of the ART: What’s the same – what’s different – Is it clinicially relevant?

Eric Arts, PhD

Western University, London (Canada)

Slideset

Heavily treatment experienced patients: Time to use once daily streamlined regimens? (Not yet available)

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Clinical case presentation (Not available)

Mona Loutfy, MD, FRCPC, MPH

Women's College Research Institute (Univ. Toronto), Canada

Session 2: Optimizing Routine HIV Clinical Management - Pharmacology -

State of the ART: What’s the same – what’s different – is it clinicially relevant?

Charles Flexner, MD

Johns Hopkins University School of Medicine, United States

Slideset

Managing drug-drug interactions in patients with multiple co-medications

Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP

Toronto General Hospital, University of Toronto, Canada

Slideset

Optimizing Routine HIV Clinical Management - Toxicity and Side Effects -

Monitoring and avoiding integrase inhibitor toxicity

Gordon Arbess, MD, CCFP

St. Michael's Hospital, Toronto (Canada)

Slideset

Reducing HIV associated inflammation – do the drugs matter?

Darrell Tan, BSc, MD, FRCPC, PhD

St. Michael’s Hospital, Toronto, Canada

Slideset

Session 3: Optimizing Routine HIV Clinical Management - Looking at the Future -

Improving care of HIV infected women: What needs to be done?

Sharon Walmsley, CM, MD, FRCPC

University Health Network, Canada

Slideset

Reduced drug regimens – Pros and Cons

Gary Rubin, MD, MCFP, AAHIVS

University of Toronto, Canada

Slideset

Novel drug delivery systems: will they have a place in routine HIV clinical care? (Not yet available)

Courtney Fletcher, PharmD

University of Nebraska, Omaha (NE, USA)

Slideset

Session 4: Roundtable Discussion -

Roundtable Discussion: What should HIV care look like in 2023?

Overview

Welcome

We would like to thank you for joining us at the Canadian HIV Clinical Forum: Integrase Inhibitors 2018 in Toronto, Canada! With excellent discussions and lectures during this meeting, it was a great success!

Presentation materials have now been posted on this website, provided that speaker's permission was granted.

Background

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.

Program Chairs

Charles Boucher, MD, PhD

Erasmus Medical Center, The Netherlands

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Local Chairs

Sharon Walmsley, CM, MD, FRCPC

University Health Network, Canada

Gary Rubin, MD, MCFP, AAHIVS

University of Toronto, Canada

Support

Endorsers